Allist

688578
81.793.16% ( -2.67 )
Delay Closed: Oct 16, 15:00:00

Current ValuationThe current P/E ratio is 13.74, below the reasonable range, cheaper than 99.62% of the time in the past 3 years, and the industry ranks 14/223, the industry Median 22.65.

13.74xP/E
Stock price¥81.79Earnings per share¥5.95

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 22.65x
011223344

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 22.65x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
000538SZYunnan Baiyao
18.14x7.35%¥94.71B
600196SHFOSUN PHARMA
18.10x14.12%¥61.37B
000999SZCR Sanjiu
12.99x3.18%¥42.55B
688578SHAllist
13.74x31.69%¥36.81B
600079SHHWHG
15.19x28.07%¥30.83B
000423SZDEEJ
17.03x11.58%¥30.40B
002603SZYILING PHARMACEUTICAL
18.30x16.88%¥25.16B
000513SZLIVZON GROUP
14.82x6.01%¥24.82B
600566SHJUMPCAN
13.03x--¥23.95B
002262SZNHWA
19.77x14.76%¥21.70B
600535SHTASLY
17.15x20.77%¥20.98B
000623SZJI LIN AO DONG
6.46x--¥20.45B
600380SHJoincare
15.39x9.59%¥18.44B
002773SZKHPG
17.95x--¥17.91B
600062SHCR Double-Crane
10.54x7.36%¥17.00B
600867SHTHDB
11.65x47.85%¥15.14B
600750SHCRJZ
16.69x5.08%¥14.62B
600267SHHISUN
14.73x39.13%¥12.94B
605507SHGuobang Pharma
17.54x--¥12.39B
600285SHLingrui Pharma
15.31x9.87%¥11.94B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.